Weight loss amelioration of non‐alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels

Abstract

NASH is associated with increased insulin resistance and altered ceramide gene expression in liver. Weight loss-mediated reversal of NASH is associated with reduced pro-ceramide gene expression in liver.